Lixte Biotechnology Holdings Inc [LIXT] Revenue clocked in at $0.00 million, up 19.41% YTD: What’s Next?

GBS Stock

Lixte Biotechnology Holdings Inc [NASDAQ: LIXT] closed the trading session at $2.83 on 2025-07-04. The day’s price range saw the stock hit a low of $2.4401, while the highest price level was $4.25.

The stocks have a year to date performance of 19.41 percent and weekly performance of 267.53 percent. The stock has been moved at 41.50 percent over the last six months. The stock has performed 100.71 percent around the most recent 30 days and changed 131.97 percent over the most recent 3-months.

If compared to the average trading volume of 857.23K shares, LIXT reached to a volume of 64128387 in the most recent trading day, which is why market watchdogs consider the stock to be active.

LIXT stock trade performance evaluation

Lixte Biotechnology Holdings Inc [LIXT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 267.53. With this latest performance, LIXT shares gained by 100.71% in over the last four-week period, additionally plugging by 41.50% over the last 6 months – not to mention a rise of 39.43% in the past year of trading.

Lixte Biotechnology Holdings Inc [LIXT]: An insightful look at the core fundamentals

Return on Equity for this stock declined to -130.27%, with Return on Assets sitting at -130.27%.

Lixte Biotechnology Holdings Inc [LIXT]: Institutional Ownership

There are presently around $15.84%, or 19.42%% of LIXT stock, in the hands of institutional investors.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.